Vanrx Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 96
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Vanrx General Information

Description

Manufacturer of aseptic filling machines intended to provide technologically advanced sterile filling devices. The company's machines use isolated robotics and machine vision to automate the packaging of injectable drugs into nested vials, syringes or cartridges, enabling health institutions and laboratories to produce safe and affordable injectable medicines with reduced risk and increased speed to patients.

Contact Information

Website
www.vanrx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Parent Company
Cytiva
Primary Office
  • 3811 North Fraser Way
  • Suite 200
  • Burnaby, British Columbia V5J 5J2
  • Canada
+1 (604) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vanrx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Vanrx‘s full profile, request access.

Request a free trial

Vanrx Patents

  • 123

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 16

    Granted

  • 7

    Pending

  • 000

    Expiring in next 12 mo

Vanrx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210206521-A1 Peristaltic pump-based apparatus and method for the controlled dispensing of fluids Pending 03-Jun-2019 00000000
US-11014697-B2 Peristaltic pump-based apparatus and method for the controlled dispensing of fluids Active 03-Jun-2019 00000000 00
US-20200377241-A1 Peristaltic pump-based apparatus and method for the controlled dispensing of fluids Granted 03-Jun-2019 000000000
CA-3097033-A1 Method, device and system for filling pharmaceutical containers Pending 07-May-2018 000000000
EP-3814718-A1 Method, device and system for filling pharmaceutical containers Pending 07-May-2018 B65B3/003
To view Vanrx’s complete patent history, request access »

Vanrx Executive Team (6)

Name Title Board Seat Contact Info
Ross Gold Co-Founder, General Manager & Director, Technical Services
Myles Degenstein Head of Finance
You’re viewing 2 of 6 executive team members. Get the full list »

Vanrx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vanrx Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Vanrx‘s full profile, request access.

Request a free trial